Spectrum Reshuffles Focus, Selling Seven Products To Aurobindo

 
• By Joseph Haas

By selling seven approved oncology/hematology products to a US affiliate of Aurobindo, Spectrum gets cash to increase focus on late-stage candidates Rolontis for neutropenia and poziotinib for solid tumors.

Two businessmen shaking hands during a meeting in the office, success, dealing, greeting & business partner concepts - soft light.

More from Anticancer

More from Therapy Areas